Laparoscopic Power Morcellators Market, by Application (Hysterectomy, Myomectomy, and Others), by End User (Hospital and Clinics, and Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh

Laparoscopic Power Morcellators Market, by Application (Hysterectomy, Myomectomy, and Others), by End User (Hospital and Clinics, and Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

A laparoscopic power morcellators is a surgical instrument used in less-invasive abdominal procedures such as laparoscopic hysterectomies and fibroid removal. Use of laparoscopic power morcellators allows for minimally invasive surgical procedures, which, when compared to open abdominal surgery, typically reduce the risk of infection and shorten the post-operative recovery period. However, when used in myomectomy or hysterectomy procedures, there is an increased risk of spreading unsuspected cancer and benign tissue within the abdomen and pelvis. The risk of unsuspected cancer increases with age, particularly in women over 50 years of age. The regulatory authorities have issued safety guidelines for laparoscopic power morcellators market players to be followed while developing devices so that it can minimize the further complications and enhance the research & development activities for upgradation of device.

Market Dynamics
Increasing prevalence of hysterectomy in women is expected to drive the growth of global laparoscopic power morcellators market. For instance, on January 30, 2021, Longitudinal Ageing Study in India (LASI) released data for percentage of women who had undergone hysterectomy among older adult women by in India during 2017-18 which indicates that 12.5% of women aged between 45 and 59, and 9.9% of women aged more than 60. Hence, such growing cases which require hysterectomy is likely to promote the adoption of laparoscopic power morcellators.

In addition, the increasing awareness by regulatory authorities for laparoscopic power morcellators is expected to increase the growth of the global laparoscopic power morcellators market over the forecast period. For instance, on December 29, 2021, the U.S. Food and Drug Administration (FDA) issued labeling guidelines for product to manufacturer of laparoscopic power morcellators to mention the warning on the box of morcellators about risk of cancer infection by using laparoscopic power morcellators which may spread the cancer or decrease the long term survival of patients. Hence, increasing the scope for market players to develop new devices of laparoscopic power morcellators to avoid the risk of cancer.

Key features of the study:
This report provides an in-depth analysis of global laparoscopic power morcellators market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global laparoscopic power morcellators market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include LiNA Medical, Blue Endo, Johnson and Johnson, Hangzhou Kangji Medical Instruments, WISAP Medical Technology, Zhejiang Geyi Medical Instrument, Karl Storz GmbH, Medtronic, Richard Wolf GmbH, Lumenis (Boston Scientific Corporation), Nouvag AG, RUDOLF Medical GmbH, and Olympus Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global laparoscopic power morcellators market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global laparoscopic power morcellators market
Detailed Segmentation:
Global Laparoscopic Power Morcellators Market, By Application:
Hysterectomy
Myomectomy
Others
Global Laparoscopic Power Morcellators Market, By End User:
Hospitals and clinics
Surgical Centers
Global Laparoscopic Power Morcellators Market, By Region:
North America
By Application:
Hysterectomy
Myomectomy
Others
By End User:
Hospitals and Clinics
Surgical Centers
By Country:
U.S.
Canada
Latin America
By Application:
Hysterectomy
Myomectomy
Others
By End User:
Hospitals and Clinics
Surgical Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Application:
Hysterectomy
Myomectomy
Others
By End User:
Hospitals and Clinics
Surgical Centers
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Application:
Hysterectomy
Myomectomy
Others
By End User:
Hospitals and Clinics
Surgical Centers
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Middle East
By Application:
Hysterectomy
Myomectomy
Others
By End User:
Hospitals and Clinics
Surgical Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Application:
Hysterectomy
Myomectomy
Others
By End User:
Hospitals and Clinics
Surgical Centers
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
LiNA Medical*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Blue Endo
Johnson and Johnson
Hangzhou Kangji Medical Instruments
WISAP Medical Technology
Zhejiang Geyi Medical Instrument
Karl Storz GmbH
Medtronic
Richard Wolf GmbH
Lumenis (Boston Scientific Corporation)
Nouvag AG
RUDOLF Medical GmbH
Olympus Corporation
“*” marked represents similar segmentation in other categories in the respective section.